long intergenic non-protein coding RNA 2242Genealiases: []
Q-omics provides the consensus-scored LINC02242 profile across patient tissues and cancer cell-line models. LINC02242 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC02242 is differentially expressed in 11, with the highest sampling consensus in BRCA. Additionally, LINC02242 RNA expression shows 8,434 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight KICH, BRCA, and ESCA as cancer lineages where LINC02242 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02242 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02242 survival associations across molecular data types. LINC02242 RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02242 RNA expression–survival associations across cancer types. High LINC02242 expression shows unfavorable associations in KICH, UVM, LAML and COAD, but favorable associations in UCS and THCA. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC02242 RNA expression.
This table summarizes LINC02242 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02242. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02242 shows lower tumor expression in BRCA, THCA and LUAD and higher tumor expression in KIRC, LIHC and BLCA. The BRCA box plot shows higher LINC02242 RNA expression in normal versus tumor tissue (log2 FC = −0.462, t-test p < 0.001).
This table shows molecular features associated with LINC02242 in patient tissues and cancer cell lines. In patient samples, LINC02242 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
